- Home
- NKTR vs CHN Comparison
NKTR vs CHN Comparison
Compare NKTR & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- CHN
- Stock Information
- Founded
- NKTR 1990
- CHN 1992
- Country
- NKTR United States
- CHN United States
- Employees
- NKTR N/A
- CHN N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- CHN Investment Managers
- Sector
- NKTR Health Care
- CHN Finance
- Exchange
- NKTR Nasdaq
- CHN Nasdaq
- Market Cap
- NKTR 160.4M
- CHN 128.4M
- IPO Year
- NKTR 1994
- CHN N/A
- Fundamental
- Price
- NKTR $0.64
- CHN $11.51
- Analyst Decision
- NKTR Strong Buy
- CHN
- Analyst Count
- NKTR 6
- CHN 0
- Target Price
- NKTR $4.92
- CHN N/A
- AVG Volume (30 Days)
- NKTR 2.8M
- CHN 31.8K
- Earning Date
- NKTR 05-08-2025
- CHN 01-01-0001
- Dividend Yield
- NKTR N/A
- CHN 0.19%
- EPS Growth
- NKTR N/A
- CHN N/A
- EPS
- NKTR N/A
- CHN N/A
- Revenue
- NKTR $98,427,000.00
- CHN N/A
- Revenue This Year
- NKTR N/A
- CHN N/A
- Revenue Next Year
- NKTR N/A
- CHN N/A
- P/E Ratio
- NKTR N/A
- CHN N/A
- Revenue Growth
- NKTR 9.21
- CHN N/A
- 52 Week Low
- NKTR $0.43
- CHN $9.00
- 52 Week High
- NKTR $1.93
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- NKTR 45.85
- CHN 38.88
- Support Level
- NKTR $0.43
- CHN $11.40
- Resistance Level
- NKTR $0.68
- CHN $11.95
- Average True Range (ATR)
- NKTR 0.08
- CHN 0.35
- MACD
- NKTR 0.01
- CHN -0.05
- Stochastic Oscillator
- NKTR 72.41
- CHN 39.91
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.